Immutep Limited American Depositary Shares
IMMP Real Time Price USDRecent trades of IMMP by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IMMP's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response Feb. 21, 2023
-
Patent Title: Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response Mar. 19, 2019
-
Patent Title: Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response Feb. 28, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of IMMP in WallStreetBets Daily Discussion
Recent insights relating to IMMP
Recent picks made for IMMP stock on CNBC
ETFs with the largest estimated holdings in IMMP
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IMMP Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.